CorVad Percutaneous Ventricular Assist System Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT06198998

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Shenzhen Core Medical Technology CO.,LTD. (from the registry)
Registry
  • NCT NCT06198998
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06198998. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-19 (actual); primary completion 2024-10-18 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CorVad Percutaneous Ventricular Assist System Study
Intervention (Device)
CorVad Percutaneous Ventricular Assist System
Lead sponsor
Shenzhen Core Medical Technology CO.,LTD. (class: industry)

Record details

Record id
cardio:ct-nct06198998
Content hash
758dd8c70945a45f959cf79455b14ba070df1ac00b51c9ef4fba09e9726cc710